SenesTech

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. It offers its ContraPest product to residential, and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

SenesTech reports record revenue growth driven by Evolve product launch

SenesTech's Q1 2024 performance was driven by the successful launch of Evolve, leading to record revenue growth. The company's strengths lie in expanding distribution channels and focusing on operational efficiencies. Challenges include achieving positive cash flow and balancing sales channels, while opportunities exist in capturing a larger market share with Evolve mouse and leveraging the Amazon store launch.

SenesTech achieves record revenue and margin growth, eyes global expansion

SenesTech delivered strong financial performance with record revenue and improved margins.
The company's product portfolio and expansion strategies position it for continued growth.
Challenges include maintaining profitability, managing competition, and balancing growth with financial stability.
Opportunities exist in market penetration, partnerships, and global expansion initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The firm focuses on rat populations through fertility control. It offers its ContraPest product to residential and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.

PHOENIX, June 11, 2020 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, encourages businesses and pest management professionals (PMP) to deploy ContraPest® in their integrated pest...

SenesTech Encourages Businesses to Deploy ContraPest

SenesTech's (SNES) CEO Ken Siegel on Q1 2020 Results - Earnings Call Transcript

SenesTech's (SNES) CEO Ken Siegel on Q3 2019 Results - Earnings Call Transcript

SenesTech, Inc. (SNES) CEO Ken Siegel on Q2 2019 Results - Earnings Call Transcript

On Tuesday, August 13, SenesTech (NASDAQ: SNES) will release its latest earnings report.

SenesTech's Earnings Outlook

Price dropped to a cheaper level of stock offering, not due to any new numbers reporting.

Buy SenesTech Now, Before The Crowd Realises It Is Only A Dip, Not A Downtrend

CEO of Senestech Inc (30-Year Financial, Insider Trades) Kenneth S Siegel (insider trades) bought 696,296 shares of SNES on 07/16/2019 at an average price of $1.35 a share.

Senestech Inc (SNES) CEO Kenneth S Siegel Bought $940,000 of Shares

SNES produces an innovative rodent pest control that tackles major challenges of rodenticides.

2 Major U.S. Metropolitan Areas Turn To A New Rat Control Method By Senes Tech

SenesTech, Inc. (SNES) CEO Ken Siegel on Q1 2019 Results - Earnings Call Transcript

Senestech, Inc. (SNES) CEO Loretta Mayer on Q4 2018 Results - Earnings Call Transcript

News for SenesTech Stock (SNES)